课题基金 / 基金详情

Molecular analysis of the abnormal expression of CD 154 in T cells as a mechanism of induction of autoinimune disease.

Molecular analysis of the abnormal expression of CD 154 in T cells as a mechanism of induction of autoinimune disease.
T 细胞中 CD 154 异常表达作为诱导自身免疫性疾病机制的分子分析。
批准号:
14570431
负责人:
HIROHATA Shunsei
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

HIROHATA Shunsei的其他基金

相似基金

相关文献

中文摘要
翻译
与IL-12一样,IFN-α也在人类Th1反应中发挥重要作用。虽然IL-12增强CD154在人T细胞上的表达,但IFN-α的作用尚未被阐明。本研究检测了IFN-α对人CD4+ T细胞中CD154表达的影响,特别关注了与Th1反应的关系。IFN-α在固定抗cd3激活CD4+ T细胞的初始阶段抑制CD154蛋白和mRNA的表达,但此后无论IL-12是否存在,IFN-α都能增强CD154蛋白和mRNA的表达。相比之下,在没有IL-12的情况下,IFN-α本身并没有增强CD4+ T细胞中IFN-γ的产生或mRNA的表达,而在IL-12存在的情况下,IFN-α却增强了IFN-γ的产生或mRNA的表达。在抗cd3激活的CD4+ T细胞中,IFN-α或IL-12均不影响CD154 mRNA的稳定性。使用含有CD154启动子区域的报告载体进行的荧光素酶分析表明,IFN-α和IL-12都上调了CD154 mRNA的转录。这些结果表明,IFN-α通过上调CD154 mRNA的转录而不依赖于诱导IFN-γ mRNA的表达,直接增强CD154在CD4+ T细胞中的表达。这些数据还表明,IFN-α诱导人类Th1反应的最佳方式可能需要IL-12的存在。
英文摘要
Like IL-12, IFN-α has been found to play an important role in human Th1 responses. Whereas IL-12 enhances CD154 expression on human T cells, the effect of IFN-α has not been elucidated. The present study examined the effects of IFN-α on CD154 expression in human CD4+ T cells, with special attention to the relationship with Th1 responses. IFN-α suppressed CD154 protein and mRNA expression in CD4+ T cells at the initial phase of activation with immobilized anti-CD3, but thereafter enhanced it irrespective of the presence of IL-12. By contrast, IFN-α by itself did not enhance IFN-γ production or mRNA expression in CD4+ T cells in the absence of IL-12, whereas it enhanced it in the presence of IL-12. Either IFN-α or IL-12 did not influence the stability of CD154 mRNA in anti-CD3 activated CD4+ T cells. Rather luciferase assays using a reporter vector containing the CD154 promoter region demonstrate that both IFN-α and IL-12 upregulate the transcription of CD154 mRNA. These results indicate that IFN-α directly enhances CD154 expression in CD4+ T cells by up-regulating the transcription of CD154 mRNA independently of the induction of IFN-γ mRNA expression. The data also suggest that the optimal induction of human Th1 responses by IFN-α might require the presence of IL-12.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
Iwai M, et al.: "Autoimmune hepatitis in a patient with systemic lupus erythematosus."Clin Rheumatol. 22. 234-236 (2003)
Iwai M 等人:“系统性红斑狼疮患者的自身免疫性肝炎。”Clin Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takayanagi M, et al.: "Myocardial infarction caused by rheumatoid vasculitis : histological evidence of the involvement of T lymphocytes."Rheumatol Int. 23. 315-318 (2003)
Takayanagi M 等人:“类风湿性血管炎引起的心肌梗塞:T 淋巴细胞参与的组织学证据。”Rheumatol Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shibuya H, et al.: "Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-α."Clin Exp Immunol. 132. 216-224 (2003)
Shibuya H 等人:“IFN-α 对人 CD4+ T 细胞中 Th1 反应和 CD154 表达的差异调节”。Clin Exp Immunol. 132. 216-224 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuda T, et al.: "Efficacy of Rebamipide as Adjunctive Therapy in the Treatment of Recurrent Oral Aphthous Ulcers in Patients with Behcet's Disease : A Randomised, Double-Blind, Placebo-Sontrolled Study"Drugs R D. 4. 19-28 (2003)
Matsuda T 等人:“瑞巴派特作为辅助疗法治疗白塞病患者复发性口腔阿弗他溃疡的功效:一项随机、双盲、安慰剂对照研究”药物 R D. 4. 19-28(
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 9 条
    Analysis of the mechanism of production of pathologic autoantibodies
    • 批准号:
      23591447
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Analysis of anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosu
    • 批准号:
      20591175
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Investigation into the roles of autoantibodies in the pathogenesis of central nervous system lupus erythematosus.
    • 批准号:
      12670438
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Analysis of the molecular machaism of defective T cell functions in reqularing B cell activation in various autoimmune diseases
    • 批准号:
      10670428
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1998
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    国内基金
    海外基金
    外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
    • 批准号:
      82102500
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      杨阳
    • 依托单位:
    外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究